Reynald Lescarbeau

Reynald Lescarbeau started their work experience in 2008 as a Ph.D. Candidate at Tufts University, where they worked until 2013. From 2013 to 2015, they worked as a Computational Biologist at Selventa. Reynald then joined Intellia Therapeutics, Inc. in 2015, starting as a Sr. Scientist and progressing to Group Leader and Associate Director. In 2018, they became the Director and Head of Informatics & Co-lead of Cell Therapy Division at Intellia Therapeutics, Inc. Reynald held this position until 2021, when they joined AvenCell as the VP and Head of US Research.

Reynald Lescarbeau earned a B.S. degree in Biomedical Engineering from Rensselaer Polytechnic Institute between 2004 and 2008. Subsequently, they pursued higher education at Tufts University from 2008 to 2013, where they obtained a Doctor of Philosophy (Ph.D.) degree in Biomedical Engineering.